End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach
NCT ID: NCT06551831
Last Updated: 2024-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
30 participants
OBSERVATIONAL
2024-07-23
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decision Support Intervention of Minor Cancer Patients and Their Parents
NCT06651242
Evaluation of Multidisciplinary Palliative Care on Terminal Cancer Patients in Taiwan
NCT01103700
Effects of Intervention on Hope, Anxiety, and Attitudes and Behavioral Intentions of Advance Care Planning in Older Adults With Cancer
NCT06061107
Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors
NCT05525299
Decision-making Preferences and Its Related Factors on Parents With Children Having Cancer
NCT06618066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Young Patients With Advanced Cancer
1. The patient has a solid tumor.
2. The age at initial cancer diagnosis is between 15 and 39 years.
3. The patient is at least 18 years old at the time of enrollment.
4. The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up.
5. After metastasis, the first-line curative treatment is ineffective.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The age at initial cancer diagnosis is between 15 and 39 years.
* The patient is at least 18 years old at the time of enrollment.
* The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up.
* After metastasis, the first-line curative treatment is ineffective.
Exclusion Criteria
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202406142RINE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.